Tolerogenic vaccination with liposomes displaying antigen and CD22/siglec G ligands induced antigen-specific tolerance in mice and reduce development of anti-drug antibodies toward FVIII in a model of hemophilia A (201) and reduced antigen-specific antibody production (202) (Table 3). The gene discussed is F8; the disease is hemophilia A.